TOP STORY
The Two Sister Study, funded in part by Susan Komen for the Cure, was conducted to examine the possible risks associated with fertility drugs and breast cancer. The results were published July 6 in the Journal of The National Cancer Institute. » More |
CONTINUING EDUCATION
Pharmacists need to gain insight into cultural competency to better serve the increasing racial and ethnic populations in the United States.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
EDITOR’S PICK
Gain a solid understanding of compendia and its impact on patient access
Drug compendia, defined as summaries of drug information, affects coverage and reimbursement decisions for pharmaceutical products, and as a result, it's important for pharmaceutical manufacturers and healthcare providers to understand the role and impact of compendia off-label uses. » Click here. |
CLINICAL NEWS
The Centers for Disease Control and Prevention recently updated its 1991 recommendations for the management of hepatitis B virus (HBV)-infected healthcare providers and students to prevent HBV transmission to patients. » More |
|
A recent study in Cancer Research suggests that modest caffeine consumption may be associated with a significantly lower relative risk of basal cell carcinoma. » More |
FDA ACTIONS
FDA is ridding the market of single-ingredient oxycodone capsules and oral liquids that are being distributed without an FDA-approved application. » More |
Survey
a) "Lock-in" programs – limiting access for high utilizers to single pharmacy and/or physician provider
b) Tighter dispensing limits on the number of units and/or prescriptions a patient can receive for controlled meds
c) Limiting coverage to only long-acting formulations with effective abuse-deterrant delivery systems
d) More broad and advanced state-based controlled prescription monitoring/surveillance systems
e) Limiting coverage of long-acting opioid prescriptions to select specialty providers
f) Other
Click here and see what your colleagues think, too.
Want to see the results of our last survey about specialty pharmacy services? Click here. |
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff |
Digital Edition |
|
|
